International Myeloma Working Group’s New Response Criteria Prompts NCCN to Revise Practice Guidelines to Include Minimal Residual Disease (MRD) Testing (https://www.myeloma.org/article/international-myeloma-working-group%25E2%2580%2599s-new-response-criteria-prompts-nccn-revise-practice)